Indeed, using a murine model, these authors showed that BCR::ABL1 is a negative regulator of CD44 necessary for cell adhesion between CML stem cells and bone marrow endothelium, thus causing a decrease in cell adhesion and enhancing CML stem cell proliferation [11]. This evidence concerns the gene CD44 and chronic myelogenous leukemia, BCR-ABL1 positive.